Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivationTakako Inoue, Yasuhito Tanaka, Kentaro Matsuura et al.|Journal of Hepatology|2021Cited by 110
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populationsHiromi Sawai, Katsushi Tokunaga, Nao Nishida et al.|BMC Medical Genetics|2012Cited by 41
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammationHaruki Uojima, Masashi Mizokami, Kazumi Yamasaki et al.|Journal of Gastroenterology|2024Cited by 23
The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysisSho Matoya, Takanori Suzuki, Kentaro Matsuura et al.|Hepatology Research|2023Cited by 22